 | Genprex, Inc. (NASDAQ:GNPX) Short Interest Update
americanbankingnews.com - March 6 at 1:16 PM |
| Genprex (NASDAQ:GNPX) Shares Up 8.9%
americanbankingnews.com - March 5 at 6:44 PM |
| Genprex (NASDAQ:GNPX) Stock Price Down 9.4%
americanbankingnews.com - March 3 at 9:48 PM |
 | BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation Schedule for March Investor Conferences - StreetInsider.com
streetinsider.com - March 1 at 7:47 PM |
 | Genprex to Participate in Upcoming March Investor Conferences - Business Wire
businesswire.com - March 1 at 2:47 PM |
 | Genprex to Participate in Upcoming March Investor Conferences
finance.yahoo.com - March 1 at 9:46 AM |
| Genprex (NASDAQ:GNPX) Trading Down 5.7%
americanbankingnews.com - February 25 at 7:58 PM |
| Genprex (NASDAQ:GNPX) Trading 6% Higher
americanbankingnews.com - February 24 at 9:36 PM |
| Genprex (NASDAQ:GNPX) Stock Price Down 6.3%
americanbankingnews.com - February 18 at 7:46 PM |
| Genprex Announces Formation of Clinical Advisory Board - Yahoo Finance
finance.yahoo.com - February 10 at 7:37 PM |
|
| BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Forms Clinical Advisory Board, Announces $25M Registered Direct Offering - StreetInsider.com
streetinsider.com - February 10 at 9:35 AM |
| Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants - Yahoo Finance
finance.yahoo.com - February 10 at 9:35 AM |
| Proactive news headlines including Tocvan Ventures, HempFusion Wellness, Milestone Scientific and Esports Entertainment Group - StreetInsider.com
streetinsider.com - February 9 at 2:05 PM |
| Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants
finance.yahoo.com - February 9 at 9:04 AM |
| Genprex Announces Formation of Clinical Advisory Board - Business Wire
businesswire.com - February 9 at 12:02 AM |
| Genprex Announces Formation of Clinical Advisory Board
finance.yahoo.com - February 8 at 7:01 PM |
 | BioMedNewsBreaks - Genprex Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day
marketwatch.com - February 5 at 5:51 PM |
| Genprex Recognizes World Cancer Day - Yahoo Finance
finance.yahoo.com - February 5 at 2:49 AM |
| BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Joins Millions to Recognize World Cancer Day - StreetInsider.com
streetinsider.com - February 4 at 9:45 PM |
| Genprex Recognizes World Cancer Day - Business Wire
businesswire.com - February 4 at 4:44 PM |
| Genprex Recognizes World Cancer Day
finance.yahoo.com - February 4 at 11:44 AM |
| Genprex Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
finance.yahoo.com - February 1 at 11:19 PM |
| Genprex Issues Shareholder Letter and Provides Corporate Update
finance.yahoo.com - February 1 at 6:18 PM |
| Genprex to Present at the Virtual Investor Conference Small and Microcap Showcase on February 4 - Yahoo Finance
finance.yahoo.com - January 27 at 9:23 AM |
| Genprex to Present at the Virtual Investor Conference Small and Microcap Showcase on February 4
finance.yahoo.com - January 27 at 9:23 AM |
| Genprex to Present its Cutting-Edge Gene Therapies at the MoneyShow Accredited Investors Virtual Expo - Business Wire
businesswire.com - January 22 at 12:31 PM |
| Genprex to Present its Cutting-Edge Gene Therapies at the MoneyShow Accredited Investors Virtual Expo
finance.yahoo.com - January 21 at 9:23 AM |
| Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer - Business Wire
businesswire.com - January 14 at 9:47 PM |
|
| Genprex to Present at NobleCon17 on January 19 - Business Wire
businesswire.com - January 14 at 4:30 PM |
| Genprex to Present at NobleCon17 on January 19
finance.yahoo.com - January 14 at 4:30 PM |
| BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Passes Final Release Tests for Manufacturing Run of Proprietary Immunogene Therapy Treatment - StreetInsider.com
streetinsider.com - January 14 at 1:31 AM |
 | Genprex achieves manufacturing milestone for immunogene therapy for upcoming lung cancer trials - Seeking Alpha
seekingalpha.com - January 13 at 8:30 PM |
| Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer - Yahoo Finance
finance.yahoo.com - January 13 at 10:29 AM |
| Genprex Achieves Major Manufacturing Milestone for REQORSA™ Immunogene Therapy for Upcoming Trials to Treat Non-Small Cell Lung Cancer
finance.yahoo.com - January 13 at 10:29 AM |
| Form SC 13G/A Genprex, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
streetinsider.com - January 4 at 3:02 PM |
 | The best-performing Austin stocks in 2020 - Austin Business Journal
bizjournals.com - December 29 at 6:22 PM |
| Genprex, Inc. Announces Closing Of $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Without Warrants - Business Wire
businesswire.com - December 25 at 2:35 AM |
| Genprex, Inc. Announces Closing Of $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules Without Warrants - Yahoo Finance
finance.yahoo.com - December 24 at 4:34 PM |
| BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters into Estimated $12-Million Securities Purchase Agreement - StreetInsider.com
streetinsider.com - December 24 at 6:33 AM |
| Let's Look at the Big Picture of Genprex
finance.yahoo.com - December 23 at 12:45 PM |
| Genprex, Inc. Announces $12 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules, Without Warrants - Business Wire
businesswire.com - December 23 at 7:44 AM |
 | 12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
benzinga.com - December 23 at 12:42 AM |
| Genprex launches $12M ATM equity offering - Seeking Alpha
seekingalpha.com - December 23 at 12:42 AM |
| Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer - Yahoo Finance
finance.yahoo.com - December 22 at 2:39 PM |
| Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer - Business Wire
businesswire.com - December 22 at 9:38 AM |
| Genprex Completes Manufacturing Scale-Up for Clinical-Grade Production of REQORSA™ Immunogene Therapy for Upcoming Acclaim-1 and Acclaim-2 Clinical Trials For Lung Cancer
finance.yahoo.com - December 22 at 9:38 AM |
| Genprex (GNPX) Looks Good: Stock Adds 6.5% in Session - Yahoo Finance
finance.yahoo.com - December 17 at 1:30 PM |
| Genprex Completes Manufacturing Technology Transfer for Novel Gene Therapy - Business Wire
businesswire.com - December 8 at 9:28 AM |
| Genprex Completes Manufacturing Technology Transfer for Novel Gene Therapy
finance.yahoo.com - December 8 at 9:28 AM |
| Genprex to Present at the Benzinga Global Small Cap Conference on December 8 - Business Wire
businesswire.com - December 4 at 6:28 PM |
